3IGV | pdb_00003igv

Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.60 Å
  • R-Value Free: 
    0.301 (Depositor), 0.298 (DCC) 
  • R-Value Work: 
    0.245 (Depositor), 0.245 (DCC) 
  • R-Value Observed: 
    0.248 (Depositor) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3IGV

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.

Ellis, D.A.Blazel, J.K.Tran, C.V.Ruebsam, F.Murphy, D.E.Li, L.S.Zhao, J.Zhou, Y.McGuire, H.M.Xiang, A.X.Webber, S.E.Zhao, Q.Han, Q.Kissinger, C.R.Lardy, M.Gobbi, A.Showalter, R.E.Shah, A.M.Tsan, M.Patel, R.A.LeBrun, L.A.Kamran, R.Bartkowski, D.M.Nolan, T.G.Norris, D.A.Sergeeva, M.V.Kirkovsky, L.

(2009) Bioorg Med Chem Lett 19: 6047-6052

  • DOI: https://doi.org/10.1016/j.bmcl.2009.09.051
  • Primary Citation Related Structures: 
    3GYN, 3IGV

  • PubMed Abstract: 

    The discovery of 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of the HCV RNA-dependent RNA polymerase (NS5B) is described. Several of these agents also display potent antiviral activity in cell culture experiments (EC50 <0.10 microM). In vitro DMPK data for selected compounds as well as crystal structures of representative inhibitors complexed with the NS5B protein are also disclosed.


  • Organizational Affiliation
    • Anadys Pharmaceuticals, Inc., 3115 Merryfield Row, San Diego, CA 92121, USA.

Macromolecule Content 

  • Total Structure Weight: 129.74 kDa 
  • Atom Count: 8,860 
  • Modeled Residue Count: 1,114 
  • Deposited Residue Count: 1,156 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
RNA-DIRECTED RNA POLYMERASE
A, B
578Hepatitis C virus (isolate BK)Mutation(s): 1 
EC: 2.7.7.48
UniProt
Find proteins for P26663 (Hepatitis C virus genotype 1b (isolate BK))
Explore P26663 
Go to UniProtKB:  P26663
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP26663
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
B80

Query on B80



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
N-{3-[(6S)-6-ethyl-1-(4-fluorobenzyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide
C22 H23 F N4 O6 S2
GOKCBBJQDMIWKP-INIZCTEOSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.60 Å
  • R-Value Free:  0.301 (Depositor), 0.298 (DCC) 
  • R-Value Work:  0.245 (Depositor), 0.245 (DCC) 
  • R-Value Observed: 0.248 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 85.911α = 90
b = 107.217β = 90
c = 126.214γ = 90
Software Package:
Software NamePurpose
CrystalCleardata collection
EPMRphasing
REFMACrefinement
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2009-12-08
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2021-10-13
    Changes: Database references, Derived calculations
  • Version 1.3: 2024-02-21
    Changes: Data collection
  • Version 1.4: 2024-04-03
    Changes: Refinement description